The Medical and Economic Aspects

Severe, acute infectious diseases and increasing antibiotic resistances represent a serious burden on the public health sector – infections are the third most common cause of deaths worldwide. 

The successful fight against such infectious diseases requires faster and more comprehensive diagnostics. Because the conventional analysis of a native sample usually takes at least two days, clinicians usually begin antibiotic treatment before that – without knowing the exact results and resistances and therefore running the risk of inadequate treatment.

Clinical studies have shown that an adequate initial treatment with antibiotics in most cases significantly improves the medical results in case of severe infections and also lowers the risk of increasing antibiotic resistance in the population.